您的位置: 首页 > 农业专利 > 详情页

ANTI-CD19 ANTIBODIES AND THEIR USE IN ONCOLOGY
专利权人:
DUKE UNIVERSITY
发明人:
YAZAWA, NORIHITO,HAMAGUCHI, YASUHITO,GRON, HANNE,TEDDER, THOMAS F.
申请号:
DK06735370
公开号:
DK1853718T3
申请日:
2006.02.15
申请国别(地区):
DK
年份:
2015
代理人:
摘要:
The disclosure relates to immunotherapeutic compositions and methods for the treatment of autoimmune diseases and disorders in human subjects, using therapeutic antibodies that bind to the human CD 19 antigen and that mediate human ADCC. The present disclosure relates to pharmaceutical compositions comprising human or humanized anti-CD 19 antibodies of the IgG1 or IgG3 human isotype. The present disclosure relates to pharmaceutical compositions comprising human or humanized anti-CD 19 antibodies of the IgG2 or IgG4 human isotype that preferably mediate human ADCC. The present disclosure also relates to pharmaceutical compositions comprising chimerized anti-CD19 antibodies of the IgG1, IgG2, IgG3, or IgG4 isotype that mediate human ADCC. In preferred embodiments, the present disclosure relates to pharmaceutical compositions comprising monoclonal human, humanized, or chimeric anti-CD 19 antibodies.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充